PsyAccess
Comprobar elegibilidad
Comprobar elegibilidad
Spravato®Verificado en registro oficialModelo de centros designados

Wojewódzki Szpital Specjalistyczny W Legnicy

Legnica, Polonia

Tratamiento y acceso

Sobre este proveedor

Los detalles a continuación están en inglés.

Wojewódzki Szpital Specjalistyczny w Legnicy is a regional multi-specialty hospital in Lower Silesia. Per NFZ data it runs program B.147 — fully funded esketamine (Spravato) for treatment-resistant depression — with no queue reported as of June 2026; program contact points are its General Psychiatric Ward, Mental Health Clinic and Day Psychiatric Ward. Its own site describes a General Psychiatric Ward with observation and open sections offering pharmacotherapy, electroconvulsive therapy, psychotherapy and occupational therapy, and a Mental Health Clinic that requires no referral, with a psychologist available daily.

Servicios y programas

Los detalles a continuación están en inglés.

  • General Psychiatric Ward (observation section and open section)
  • Day Psychiatric Rehabilitation Ward and Day Psychiatric Ward (general)
  • Mental Health Clinic (PZP) — no referral required, psychologist available daily
  • Pharmacotherapy, electroconvulsive therapy, individual and group psychotherapy, psychoeducation, occupational therapy

Preguntas frecuentes

Los detalles a continuación están en inglés.

How do I access the esketamine program in Legnica?

Contact the hospital's psychiatric service — ward secretariat +48 76 721 14 22 or Mental Health Clinic registration +48 76 721 17 03. Program qualification requires being 18-75 with moderate-to-severe depression unresponsive to at least two antidepressants; bring your medical records and a referral.

Do I need a referral to be seen?

The hospital's Mental Health Clinic accepts patients without a referral, so a psychiatrist there can assess you; enrollment in program B.147 itself is decided by the center's physicians against the NFZ criteria.

What is covered by the program?

The full course — esketamine nasal spray administered under supervision at the center, alongside a prescribed oral antidepressant, for up to 34 weeks — is funded by the NFZ at no cost to insured patients.

¿Considerando alternativas? One of the NFZ program B.147 centers — see all program centers in Poland in the directory and the Poland access guide.

Verificación

Este registro se tomó directamente de un registro oficial o una lista de programa y se revisa de nuevo con una cadencia continua.

¿Detectó un error? Vea nuestra metodología (en inglés) — allí se explica cómo se comprueban los registros y cómo notificar una corrección.